Considering the crucial role of the SOS/MEK1/ERK2 signaling axis in leptin signaling in various cancers (not only in neuroblastoma) [30], the obtained results encourage further investigation of SM as a potent inhibitor of the tumor-promoting potency of leptin. Here, MAPK1 is linked to cancer.